Read + Share
Maceski AM, Benkert P, Einsiedler M, Schaedelin S, et al. GFAP and NfL as predictors of disease progression and relapse activity in
fingolimod-treated multiple sclerosis. Brain 2025 Nov 14:awaf433. doi: 10.1093.
PMID: 41237262
|
 |
|
Maceski AM, Benkert P, Einsiedler M, Schaedelin S, et al. GFAP and NfL as predictors of disease progression and relapse activity in
fingolimod-treated multiple sclerosis. Brain 2025 Nov 14:awaf433. doi: 10.1093.
PMID: 41237262
|
|
|
|